Methadone Destabilizes Cardiac Repolarization During Sleep.
Methadone Destabilizes Cardiac Repolarization During Sleep.
复制标题
DOI:
10.1002/cpt.2368
复制
发表时间:
2021-10
影响因子:
6.7
通讯作者:
Haigney MC
中科院分区:
文献类型:
--
作者:
Solhjoo S;Punjabi NM;Ivanescu AE;Crainiceanu C;Gaynanova I;Wicken C;Buckenmaier C 3rd;Haigney MC
Methadone, a widely-prescribed medication for chronic pain and opioid addiction, is associated with respiratory depression and increased predisposition for torsades de pointes, a potentially fatal arrhythmia. Most methadone-related deaths occur during sleep. The objective of this study was to determine whether methadone’s arrhythmogenic effects increase during sleep, with a focus on cardiac repolarization instability using QT variability index (QTVI), a measure shown to predict arrhythmias and mortality. Sleep study data of 24 patients on chronic methadone therapy referred to a tertiary clinic for overnight polysomnography were compared with two matched groups not on methadone: 24 patients referred for overnight polysomnography to the same clinic (Clinic group), and 24 volunteers who had overnight polysomnography at home (Community group). Despite similar values for heart rate, heart rate variability, corrected QT interval, QTVI and oxygen saturation (SpO2) when awake, patients on methadone had larger QTVI (p=0.015 vs Clinic, p<0.001 vs Community) and lower SpO2 (p=0.008 vs Clinic, p=0.013 vs Community) during sleep, and the increase in their QTVI during sleep versus wakefulness correlated with the decrease in SpO2 (r=-0.54, p=0.013). QTVI positively correlated with methadone dose during sleep (r=0.51, p=0.012) and wakefulness (r=0.73, p<0.001). High-density ectopy (>1000 premature beats per median sleep period), a precursor for torsades de pointes, was uncommon but more frequent in patients on methadone (p=0.039). This study demonstrates that chronic methadone use is associated with increased cardiac repolarization instability. Methadone’s pro-arrhythmic impact may be mediated by sleep-related hypoxemia which could explain the increased nocturnal mortality associated with this opioid.
登录
查看更多内容
影响因子:
39.3
作者:
Noda, T;Shimizu, W;Kamakura, S
通讯作者:
Kamakura, S
影响因子:
24
作者:
Haigney, MC;Zareba, W;Moss, AJ
通讯作者:
Moss, AJ
影响因子:
5.9
作者:
Chugh, Sumeet S.;Socoteanu, Carmen;Gunson, Karen
通讯作者:
Gunson, Karen
DOI:
10.1111/j.1540-8167.2006.00421.x
发表时间:
2006-06-01
影响因子:
2.7
作者:
Haigney, MCP;Alam, S;Cantilena, L
通讯作者:
Cantilena, L
影响因子:
39.2
作者:
Kao, David;Bartelson, Becki Bucher;Krantz, Mori J.
通讯作者:
Krantz, Mori J.